Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam in Procedural Sedation
NCT07362173Phase 4Active, not recruiting
- Sponsor
- Iuliu Hațieganu University of Medicine and Pharmacy
- Start
- Mar 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam, sponsored by Iuliu Hațieganu University of Medicine and Pharmacy. Started Mar 2025; status: active, not recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT07362173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07362173.